Search Orphan Drug Designations and Approvals
-
Generic Name: | abatacept |
---|---|
Date Designated: | 05/30/2013 |
Orphan Designation: | Treatment of type 1 diabetes mellitus patients with residual beta cell function |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Orban Biotech LLC 64 Aspinwall Avenue Brookline, Massachusetts 02446 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-